Artificial intelligence (AI) agents are a breeze to create using Microsoft Copilot Studio, and almost just as easy to manipulate into divulging sensitive corporate data. Despite broad security ...

Anthropic has added web and mobile interfaces for Claude Code, its immensely popular command-line interface (CLI) agentic AI coding tool. The web interface appears to be well-baked at launch, but the ...

Oct 13 (Reuters) - Brookfield Asset Management (BAM.TO), opens new tab said on Monday it would invest up to $5 billion in Bloom Energy's (BE.N), opens new tab fuel cell technology to power data ...

If you were holding a competition for the scummiest business model, then data brokers would be very high up the list. These companies make money by buying personal data from app and website owners and ...

A small but enthusiastic group of neuroscientists is exhuming overlooked experiments and performing new ones to explore whether cells record past experiences — fundamentally challenging what memory is ...

Scientists have uncovered a surprisingly simple “tissue code”: five rules that choreograph when, where, and how cells divide, move, and die, allowing organs like the colon to remain flawlessly ...

The FDA has rejected Capricor Therapeutics’ filing for approval of a Duchenne muscular dystrophy (DMD) cell therapy, raising questions about whether the agency's new leadership may be rowing back from ...

Ever since artificial intelligence (AI) drug developer Xaira Therapeutics launched in April 2024 with a jaw-dropping $1 billion in committed capital and a star-studded leadership lineup—including ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Reeves is an associate professor of pediatrics and epidemiology at the University of Michigan and the principal investigator of the Michigan Sickle Cell Data Collection program. In December 2023, a ...

Cullinan Therapeutics is paying $20 million upfront for a BCMAxCD3 bispecific T-cell engager that the biotech plans to pair with its existing CD19 candidate. In return for the ex-China rights to its ...

June 4 (Reuters) - Class actions rarely go to trial, which is why a case against Google is proving to be an outlier. The tech giant is defending itself before a jury in Santa Clara County, California, ...